What It’s Actually Like to Work With Me During Cancer Treatment
If you’re navigating colon cancer, breast cancer, colorectal cancer, brain cancer, prostate cancer, melanoma, TNBC, or another complex diagnosis, you’ve probably discovered something unsettling: cancer treatment is rarely truly personalized.
Most oncology decisions are based on population averages. Standard chemotherapy, radiation therapy, immunotherapy, or targeted drugs like Keytruda are recommended because they work “most of the time.” But most of the time is not the same thing as optimized for your tumor biology.
At Elevating Cancer Treatment, my work focuses on precision cancer strategy — using genomics, biomarkers, biopsy data, PET scan interpretation, and cancer biology to help cancer patients think more clearly and act more strategically.
Reducing Fear With Real Clinical Data
One client was told immunotherapy didn’t improve survival. That was technically true — based on outdated data.
But updated long-term melanoma follow-up shows that approximately 34% of advanced patients treated with Keytruda remain cancer-free beyond ten years. That’s not hype. That’s modern oncology data.
Understanding survival curves, biomarker subgroups, and real outcomes changes decision-making. Fear shrinks when the data is accurate.
Comprehensive Genomic Testing and Biomarkers
Many patients believe they’ve had genomic testing. Often, they haven’t.
Testing one gene is not precision medicine. Modern NGS panels analyze thousands of mutations, tumor mutational burden (TMB), receptor expression, and resistance pathways.
For example:
- A B2M mutation may render certain immunotherapy combinations ineffective.
- Triple negative breast cancer (TNBC) may express androgen receptor, altering treatment strategy.
- Neuroendocrine tumors may express somatostatin receptors, opening targeted radiation therapy options.
- Prostate cancer signaling may differ dramatically based on androgen receptor dynamics.
Without complete biomarker review, cancer treatment becomes guesswork.
Avoiding Costly Mistakes
Precision oncology isn’t about adding more drugs. Sometimes it’s about avoiding the wrong ones.
We review:
- Whether chemotherapy aligns with tumor biology
- If immunotherapy timing and dosing are optimized
- Whether steroids are undermining immune activation
- If supplements or integrative medicine approaches interfere with treatment
- Whether PET scans or imaging were interpreted correctly
In some cases, unnecessary biopsies can be avoided. In others, incomplete profiling leads to missed opportunities.
Cancer biology compounds over time. Small early decisions can dramatically change long-term outcomes.
Strategy, Not Generic Advice
This is not one-size-fits-all wellness coaching. It’s not keto and cancer generalized advice. It’s not “boost your immune system” platitudes.
It’s:
- Interpreting biopsy data
- Reviewing NGS reports
- Evaluating biomarkers
- Optimizing radiation treatment strategy
- Translating oncology language into clear action steps
I work with oncologists, not against them — providing literature citations and precise language that elevates conversations.
Clarity. Precision. Strategy.
Because when you understand your tumor’s biology, cancer treatment stops feeling random — and starts becoming deliberate.
Accurate science saves lives — and it starts with rejecting simple myths in favor of real understanding. Stay curious.
Disclaimer: This content is for educational purposes only and is not medical advice. It does not replace guidance from your healthcare provider. Cancer and treatment decisions are highly individual—always consult your physician or qualified healthcare professional regarding your specific situation.
A full disclaimer is available Terms and Conditions.